Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Pituitary

Search In Journal Title:

Abbravation: Pituitary

Search In Journal Abbravation:

Publisher

Kluwer Academic Publishers

Search In Publisher:

DOI

10.1016/0045-7949(73)90036-9

Search In DOI:

ISSN

1573-7403

Search In ISSN:
Search In Title Of Papers:

Modulation of VEGF/Flk1 receptor expression in th

Authors: Matilde Lombardero Sergio Vidal Robert Hurta Alba Román Kalman Kovacs Ricardo V Lloyd Bernd W Scheithauer
Publish Date: 2006/08/30
Volume: 9, Issue: 2, Pages: 137-143
PDF Link

Abstract

Both vascular endothelial growth factor VEGF and its receptor Flk1 are expressed in normal pituitary cells and in the prolactin and growth hormoneproducing GH3 cell line of the rat thus suggesting autocrine/paracrine function Regulation of the Flk1 receptor system in pituitary cells is poorly understood but evidence suggests that upregulated growth factors play a role in its expression and activation To study the role of growth factors in this process we examined changes in VEGF and Flk1 expression in GH3 cells following varied exposure to βFGF EGF and TGFβ1 Immunofluorescence labelling and laser scanning cytometry were used to measure changes in VEGF and Flk1 expression Results showed that βFGF EGF and TGFβ upregulated the VEGF/FLK1 receptor system Distinct patterns of activation were detected At 2 hours EGF and TGFβ caused no significant changes in VEGF and Flk1 expression however βFGF upregulated VEGF expression in 99 of cells but only induced modest changes in Flk1 overexpression A similar percentage of cells overexpressed VEGF after 24hour incubation with βFGF but more prominent Flk1 overexpression was detected At 24 hours EGF and TGFβ1 induced a significant increase in both VEGF and Flk1 expression In summary our findings show that VEGF/Flk1 expression in pituitary cells may be altered by different growth factors This may affect angiogenesis and the progression of pituitary tumors


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. IGF-I assays: current assay methodologies and their limitations
  2. Erratum to: An endoscopic modification of the simultaneous ‘above and below’ approach to large pituitary adenomas
  3. Somatostatin receptor ligands in the treatment of acromegaly
  4. Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States
  5. Primary hypothyroidism presenting as pseudoacromegaly
  6. Sellar meningiomas: an endocrinologic perspective
  7. Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment
  8. Pituitary tumor apoplexy in patients with Cushing’s disease: endocrinologic and visual outcomes after transsphenoidal surgery
  9. A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas
  10. Sellar and clival plasmacytomas: case series of 5 patients with systematic review of 65 published cases
  11. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission
  12. Sellar plasmacytomas: a concise review
  13. Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study
  14. Two cases of Kallmann syndrome associated with empty sella
  15. Multiple head and neck tumors following treatment for craniopharyngioma
  16. Acromegalic gigantism, physicians and body snatching. Past or present?
  17. Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
  18. Adipsic diabetes insipidus in adult patients
  19. Pituitary gland and β-catenin signaling: from ontogeny to oncogenesis
  20. Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory
  21. A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred

Search Result: